Login to Your Account



REVIEWING NONPUBLIC DATA

New rating agency for drugs, investors & companies benefit

By Brian Orelli
Contributing Writer

Monday, July 28, 2014

Claravant Analytics LLC is looking to become the drug industry's version of a credit rating agency, doing independent reviews of a drug's likelihood of gaining regulatory approval.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription